These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 4127245)
21. Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays? Venning GR Br Med J (Clin Res Ed); 1983 Jan; 286(6361):289-92. PubMed ID: 6218859 [TBL] [Abstract][Full Text] [Related]
22. IV. Recent medicine legislation in the United Kingdom and its effect on manufacturing practice. Fishburn AG Bull Parenter Drug Assoc; 1974; 28(4):174-80. PubMed ID: 4852607 [No Abstract] [Full Text] [Related]
24. Can the Food and Drug Administration ensure that our pharmaceuticals are safely manufactured? Hubbard WK Arch Intern Med; 2009 Oct; 169(18):1655-6. PubMed ID: 19822821 [No Abstract] [Full Text] [Related]
25. GMPs vs GCPs: United States Pharmacopeia General Chapters. Allen LV Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791 [No Abstract] [Full Text] [Related]
26. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting]. Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282 [No Abstract] [Full Text] [Related]
27. Topical chloramphenicol is an outmoded treatment. Doona M; Walsh JB BMJ; 1998 Jun; 316(7148):1903. PubMed ID: 9632423 [No Abstract] [Full Text] [Related]
28. [Factory inspection--a method of drug control]. Bill E Lakartidningen; 1968 Jun; 65():Suppl 2:97-100. PubMed ID: 5712533 [No Abstract] [Full Text] [Related]
29. Safety of drugs. Br Med J; 1968 Sep; 3(5621):758. PubMed ID: 5676711 [No Abstract] [Full Text] [Related]
30. Production amount of chloramphenicol and mortality rate of aplastic anemia in Japan. Shimizu H; Kuroishi T; Tominaga S; Okada H; Aoki K Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):689-96. PubMed ID: 506652 [No Abstract] [Full Text] [Related]
31. Immortality for old drugs? Herxheimer A Lancet; 1984 Aug; 2(8397):291-2. PubMed ID: 6146846 [No Abstract] [Full Text] [Related]
32. Quality control of drugs. Whittet TD J Ir Med Assoc; 1968 Oct; ():Suppl 1:15-9. PubMed ID: 5701292 [No Abstract] [Full Text] [Related]
33. Worldwide variation in use of chloramphenicol. Kumana CR; Li KY; Chan PY Lancet; 1987 Aug; 2(8556):449-50. PubMed ID: 2887745 [No Abstract] [Full Text] [Related]
34. Hospital procedures for a drug recall. Dimens Health Serv; 1978 Mar; 55(3):34-5. PubMed ID: 640284 [No Abstract] [Full Text] [Related]
35. Trying times at the FDA--the challenge of ensuring the safety of imported pharmaceuticals. Schweitzer SO N Engl J Med; 2008 Apr; 358(17):1773-7. PubMed ID: 18434648 [No Abstract] [Full Text] [Related]
36. [Suggestions and recommendations for standardization of the systemic "routine" controls during the production of pharmaceutical forms and their manufacturing]. Bellentani L; Carugati E; Colombo A; Ingraffia P Boll Chim Farm; 1971 Jun; 110(6):298-311 contd. PubMed ID: 5110577 [No Abstract] [Full Text] [Related]
37. Triazolam licensing in UK. Brahams D Lancet; 1993 Jun; 341(8860):1587. PubMed ID: 8099654 [No Abstract] [Full Text] [Related]
39. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads. Kellerman R; Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544 [No Abstract] [Full Text] [Related]
40. Criminal conviction for distribution of a drug not approved by the FDA. Brushwood DB Am J Hosp Pharm; 1991 Apr; 48(4):747-9. PubMed ID: 2042679 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]